Mark George Culmer
Management
Thank you, António, and good morning, everyone. I'll give my usual overview of the financial performance and position of the business. Beginning with the P&L. As you've just heard, we've made further significant progress on our strategy in the first 6 months, and this is reflected in the group's financial performance. Underlying profit increased 32%, GBP 3.8 billion, with movements in total income more than offset by 6% reduction in underlying costs, excluding FSCS timing effects and a 58% improvement in impairments. Excluding SJP from last year's numbers, income was up 4%, while underlying profit was up 58%, with underlying jaws a positive 8%. Statutory profit before tax for the group was GBP 863 million, and include simplification costs, TSB builds and dual running costs, as well as legacy and other items such as the ECN exchange that we flagged in Q1. Statutory profit after tax was GBP 699 million with effective tax rate of 19%, largely reflecting the impact of tax-exempt disposals predominantly swept in the first quarter. Looking at P&L in more detail, and starting with net interest income. NII was up 12% on prior year at GBP 5.8 billion. As in the first quarter, this was driven by better deposit pricing, lower wholesale funding costs and loan growth in key segments, partly offset by expected asset pricing headwinds and run-off reductions. In Q2, we'll also have the accounting benefit of the ECN exchange, which boosted income by around GBP 100 million in the quarter. The net interest margin for the first half is 2.40%, is 39 basis points higher than first half of 2013, and 17 basis points higher than the second 6 months. In the second quarter, the margin strengthened to 2.48%, mainly due to a 10-basis-point benefit from the ECN exchanges. Looking forward, we would expect the margin to stabilize at around the second quarter level for the remaining 6 months of the year, giving us an expected full year net interest margin of around 2.45%. This is obviously a further improvement from the revised guidance of 2.40% that we gave in Q1. Total other income. The operating environment for other income remains challenging. In the second quarter, we've seen stabilization with Q2 margin ahead of Q1 at GBP 1.7 billion, bringing the 6 months total for other income to GBP 3.4 billion. As we said out in Q1, other income has been affected by disposals, the challenging financial and capital markets operating environments in commercial banking and the impact of regulatory changes in our key businesses, particularly in insurance where we've also seen higher weather claims. Looking forward, disposals will have less of an impact with our underlying businesses continuing to form resiliently, we would expect the quarterly total for other income to be close to the Q2 level. Turning to costs. Costs totaled GBP 4.7 billion in the first half. This is 2% lower than last year and 6% lower excluding FSCS costs, which are recognized in the first half of this year, as opposed to the second half in previous years. Our market-leading cost-to-income ratio now stands at 50.5%, 2.2 percentage points better than the year ago, adjusting for SJP. Disposals and run-off accounted for GBP 254 million of the year-on-year cost reduction, while Simplification delivered further incremental savings of GBP 235 million. Simplification has now achieved annual run rate savings of GBP 1.8 billion and remain on track to achieve our target of GBP 2 billion of run rate cost savings by the end of the year. Included within the GBP 4.7 billion of costs is GBP 0.2 billion of TSB's cost base, giving us group costs of GBP 4.5 billion for this first 6 months. And we, therefore, remain on target to deliver a full year 2014 costs base, excluding TSB, of around GBP 9 billion. On impairments, we've seen a further 58% reduction in the impairment charge in the first half to GBP 758 million. With the AQR improving significantly to 30 basis points compared to 69 and 45 basis points in the first and second half of 2013, respectively. Impairments reduced in every division and continued to benefit from better credit quality, improving economic conditions, provision releases and the reductions in the run-off portfolio. As a result of the better-than-expected trends across our portfolios, we are revising our full year guidance, and we now expect the AQR for full year to be around 35 basis points, again a further improvement from the revised guidance of around 45 that we gave in Q1. In terms of impaired loans and coverage, the quality of the group's loan portfolio continues to improve. Impaired loans now stand at 5% of total advances. This compares to 6.3% in December and 8.6% at the end of 2012, with reduction in reflected disposals and reductions from the core business and run-off portfolio. At the same time, we've also seen improvement in coverage, with the coverage ratio increasing to 54% from 50% from the 2013 year end and from 48% at the end of 2012. Looking at underlying profitability at a divisional level, we've driven strong increases in Retail, Commercial and Consumer Finance, as well as improvements in run-off due to lower impairments and other items. In Retail, we continue to deliver strong profits and returns, with a 32% increase in underlying profit, reflecting net interest income, which was up 15%, as well as a 40% reduction impairments. Reported costs were 10% higher than last year. This is largely due to accelerated timing of FSCS and the reallocation of the support costs previously charged to TSB. In commercial, the 35% improvement in underlying profit is a very strong performance in tough market conditions. Underlying profit benefited from a very significant reduction impairments, while income was 3% higher, with other income more than offset by increase in net interest income. Consumer Finance also benefited from reduced impairment charges, as well as higher income from Asset Finance. And these more than offset the increased investments in the business and were the key drivers of the 5% increase in underlying profit. Insurance, as you know, was impacted by one-off charges and adverse weather, with underlying profit down by 18%. Most of these one-offs were, however, Q1 items, and the Q2 result of GBP 323 million is more than double the profits delivered in the first 3 months. Finally, TSB saw a significant improvement in reported performance. This is largely due to reallocation of the support costs I just mentioned. TSB is reported within our results on a stand-alone basis, with its ongoing direct costs including underlying profits and dual running costs shown below the line. Set out here is the usual reconciliation from underlying to statutory profit. The GBP 857 million charge in asset sales and volatile items mostly comprises the GBP 1.1 billion relating to the ECN exchange, as well as fair value unwind charge. These are partly offset by credit from the changes to our defined benefit pension scheme and gains on disposals. As you recall, the gain in 2013 of GBP 793 million was dominated by gains on sales of government bonds, and there've been no such sales in 2014. On Simplification, we expensed GBP 519 million in the first half. This brings total program costs to GBP 2.2 billion out of an estimated total costs of around GBP 2.4 billion will be expensed by the time the program concludes at the end of this year. TSB costs in the half amounted to GBP 309 million and comprised build costs of GBP 171 million and dual running costs of GBP 138 million, again bringing the total incurred to date to GBP 1.8 billion. These dual running costs will continue be shown outside of underlying profit until we de-consolidate TSB. Legacy charges totaled GBP 1.1 billion, and included a further GBP 600 million for PPI, GBP 226 million for the LIBOR and BBA repo settlements announced earlier this week, just over GBP 200 million for retail conduct provisions and GBP 50 million for interest rate hedging product sales. Finally, the tax charge in the half is GBP 164 million, with as previously mentioned, the 19% effective rate mostly reflecting tax-exempt gains on disposals. For the full year, I expect a number of those items, which impacted statutory profit in the first 6 months, to either not be repeated or to reduce in the second half. Given our continued strong underlying profitability and in contrast to the last couple of years, I therefore expect full year statutory profit before tax to be significantly ahead of the first half's total. On PPI, as just mentioned, we've increased our provision by GBP 600 million to reflect an upward revision in expected claims volumes, as well as additional PBR and related costs. Costs were initiated claims volumes were down in the second quarter with the average of 39,000 per month in Q2, 7% lower than Q1 and 27% lower in the second quarter of 2013. Claims volumes are, however, still slightly higher than previously forecast. Around 2/3 of the increase in the provision relates to higher expected future volumes and associated expenses. On the PBR, we've now substantially completed the proactive mailings related to GBP 2.8 million PPI policies, where we've identified the potential risk of missed sale, with over 95% of all PBR customers mailed. While response rates in most cohorts were in line with expectations, certain asset finance rates are running ahead, and we're also seeing a higher number of policies per customer than expected. In terms of our overall cash spend, this continues to run at about GBP 200 million per month. I think the 3 key elements of spend, I'd expect PBR costs to be substantially complete in the first quarter of next year and remediation in the first half. Ongoing costs, at that point, will overwhelmingly relate to reactive complaints. I would, therefore, expect the cash out to be very significantly less than the current level. Turning into the balance sheet. Our strong balance sheet and key ratios continue to improve. Over the first half, we generated some GBP 19 billion funds, thereby GBP 8 million reduction in run-off portfolio and deposit growth of GBP 7 billion, which have driven a further reduction of the group's loan-to-deposit ratio to 109%. The GBP 8 billion reduction in the run-off portfolio is well ahead of the run rate to hit our original full year guidance of GBP 23 billion. And we now expect the portfolio to be below GBP 20 billion at the end of the year. Elsewhere on the balance sheet, equity increased by 17%, driven by underlying profits in the issue of over of GBP 5 billion of AT1 securities as part of the ECN exchange. Underlying profits also contributed to the 2% increase in TNAV to 49.4p, while the reduction in TNAVs during the second quarter primarily reflected legacy items and the charges relating to the ECNs. Finally, RWAs on a fully loaded basis reduced by 6% to GBP 257 billion, as we continue to improve our low-risk -- implement our low-risk strategy and de-risk the balance sheet. The 6% reduction takes the total decrease in RWAs over the last 3 years to 33%, reflecting progress we've made in de-risking the balance sheet and particularly the run-off reduction in noncore and run-off assets. Finally, looking at capital leverage. As you've heard our fully loaded common equity tier 1 position increased to 11.1% from 10.7% in Q1 and 10.3% at the year end. This increase is obviously after the GBP 1.1 billion of net charges related to the ECNs, as well as PPI, another legacy, and has again been driven by underlying profits, the dividends received from insurance and the reduction in risk-weighted assets. Our leverage remained in a strong position. We increased our ratio on a Basel III 3 basis to 4.5% from 3.8% to the start of the year, including a 50-basis-point benefit from our AT1 issuance adding to the positive effect of strong underlying profitability. The continued strengthening of our key capital and leverage ratios are clear evidence of the successful execution of our low-risk strategy and the capital-generative nature of our business. That concludes my review. And I'd now like to hand back over to António. António Mota de Sousa Horta-Osório: Thank you, George. In summary, our 3-year strategic plan, as set out in June 2011, has now been substantially delivered. We have strengthened the balance sheet, reshaped and simplified the organization and stepped up the investment in new and improved products and services for customers by reinvesting more than 1/3 of our Simplification program's cost savings. At the same time, we have addressed head-on and sought to resolve our legacy issues. This week's extremely disappointing announcement on past behavior demonstrates that we absolutely took the right decision to refocus the group on becoming a low-risk U.K. retail and commercial bank, focused upon the customer and ensuring we operate to the highest standards. It is that strategy which will ensure that we don't have issues in the future like the past cases we are dealing with. By seeking to place customers at the heart of everything we do, having a low-risk culture and prudent risk appetite and by achieving a leading cost position, we have been able to grow income, restore profitability and improve returns. We have continued to grow lending in each of our key customer segments and further strengthened our capital position. I believe the increase in underlying profits and returns in the first half of 2014 clearly demonstrates the strength of our chosen business model. Before I finish, I think it's worth touching upon the regulatory environment in which the group operates. As well as the PRA stress tests announced in April, the Bank of England has recently issued a consultation paper focused on bank leverage. Lloyds is very well placed regarding these indicator, with a leverage ratio of 4.5% versus a current minimum of 3%. We also continue to work with the relevant authorities on the evolution of regulation in relation to ring fencing. Given that we are now predominantly a U.K.-focused retail and commercial bank, we anticipate that the vast majority of our business will be within the ring fence. Therefore, not anticipating any shift or uncertainties in relation to our strategic direction. It is clear to me that the regulatory environment in which banks exists has changed, I would say, forever. I strongly believe that our strategy and business model ensure that we are very well positioned to respond to this new regulatory environment. As a result of the progress we have made on implementing this strategy and the consequent improvement in our performance, the U.K. government, in March of this year, was able to continue the process of returning Lloyds to full private ownership at a price of 75.5p, with its shareholding now reduced to 24.9%. We are increasingly well positioned to continue to support and benefit from the accelerating U.K. economic recovery, and I am confident in the delivery of strong and stable returns to shareholders as a consequence of the strategic decisions we took in 2011 and of their successful and timely implementation. Consequently, I can confirm, as previously stated, that we will be applying to the PRA in the second half of the year, seeking approval to resume dividend payments starting at a modest level. Also looking forward, with many of the targets we set out for our organization in 2011 already achieved, we have been looking at how we will take the group into 2015 and beyond. This plans are well developed, and we intend to share them with you in the autumn. Thank you. This concludes our presentation. We'd now like to take any questions you may have. Raul Sinha - JP Morgan Chase & Co, Research Division: It's Raul Sinha from JPMorgan, Cazenove. Sorry, I got to mic first, so I'll go first. Can I have 2, please? Firstly, on capital. You're now at 11.1% on Bal III Core Tier 1. And clearly, based on what you're flagging for the second of the year, this is going to continue to build pretty strongly. In the past, you've talked about 11% being a sort of broadly the right level for you. So I was just wondering if you can talk about what you plan to do with the bucket loads of excess capital that you will have. That will be helpful. And then, secondly, António, if I can just clarify, does the dividend payment -- is the dividend payment subjective to stress test? Or is that a conversation that's separate with the PRA?